Lv1
72 积分 2021-02-18 加入
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
1个月前
已完结
Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights
2个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
7个月前
已完结
皖公网安备34019202002308
